Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/2476157

Download in:

View as

General Info

PMID
2476157